×

Wei Qiu, Ph.D.

Professor

Surgery

Bio

Hobbies include basketball and tennis.

Publications/Research Listings

  • Keating, CR; Calvisi, DF; Qiu, W High-fat diet-induced AKT-palmitoylation in hepatocellular carcinoma: a breakthrough mechanistic investigation. Gut
  • Hou, W; Gad, SA; Ding, X; Dhanarajan, A; Qiu, W Focal adhesion kinase confers lenvatinib resistance in hepatocellular carcinoma via the regulation of lysine-deficient kinase 1. Molecular carcinogenesis
  • Buttell, A; Qiu, W The action and resistance mechanisms of Lenvatinib in liver cancer. Molecular carcinogenesis
  • Malnassy, G; Keating, CR; Gad, S; Bridgeman, B; Perera, A; Hou, W; Cotler, SJ; Ding, X; Choudhry, M; Sun, Z; Koleske, AJ; Qiu, W Inhibition of Abelson Tyrosine-Protein Kinase 2 Suppresses the Development of Alcohol-Associated Liver Disease by Decreasing PPARgamma Expression. Cellular and molecular gastroenterology and hepatology
  • Liu, X; Khalafalla, M; Chung, C; Gindin, Y; Hubchak, S; LeCuyer, B; Kriegermeier, A; Zhang, D; Qiu, W; Ding, X; Fang, D; Green, R Hepatic Deletion of X-box Binding Protein 1 in Farnesoid X Receptor Null Mice Leads to Enhanced Liver Injury. Journal of lipid research
  • Qiu, W; Hou, W Integrin subunit beta 8 contributes to lenvatinib resistance in liver cancer. FASEB journal : official publication of the Federation of American Societies for Experimental Biology ; 36 Suppl 1
  • Hou, W; Bridgeman, B; Malnassy, G; Ding, X; Cotler, SJ; Dhanarajan, A; Qiu, W Integrin subunit beta 8 contributes to lenvatinib resistance in HCC. Hepatology communications
  • Wang, F; Breslin S J, P; Qiu, W Novel oncogenes and tumor suppressor genes in hepatocellular carcinoma. Liver research ; 5 4
  • Wang, H; Qiu, W EPHA2, a promising therapeutic target for hepatocellular carcinoma. Molecular & cellular oncology ; 8 3
  • Song, X; Xu, H; Wang, P; Wang, J; Affo, S; Wang, H; Xu, M; Liang, B; Che, L; Qiu, W; Schwabe, RF; Chang, TT; Vogl, M; Pes, GM; Ribback, S; Evert, M; Chen, X; Calvisi, DF Focal Adhesion Kinase (FAK) promotes cholangiocarcinoma development and progression via YAP activation. Journal of Hepatology
  • Wang, F; Malnassy, G; Qiu, W The Epigenetic Regulation of Microenvironment in Hepatocellular Carcinoma. Frontiers in oncology ; 11
  • Wang, H; Hou, W; Perera, A; Bettler, C; Beach, JR; Ding, X; Li, J; Denning, MF; Dhanarajan, A; Cotler, SJ; Joyce, C; Yin, J; Ahmed, F; Roberts, LR; Qiu, W Targeting EphA2 suppresses hepatocellular carcinoma initiation and progression by dual inhibition of JAK1/STAT3 and AKT signaling. Cell reports ; 34 8
  • Wang, F; Hou, W; Chitsike, L; Xu, Y; Bettler, C; Perera, A; Bank, T; Cotler, SJ; Dhanarajan, A; Denning, MF; Ding, X; Breslin, P; Qiang, W; Li, J; Koleske, AJ; Qiu, W ABL1, Overexpressed in Hepatocellular Carcinomas, Regulates Expression of NOTCH1 and Promotes Development of Liver Tumors in Mice. Gastroenterology ; 159 1
  • Pulido, I; Ollosi, S; Aparisi, S; Becker, JH; Aliena-Valero, A; Benet, M; Rodríguez, ML; López, A; Tamayo-Torres, E; Chuliá-Peris, L; García-Cañaveras, JC; Soucheray, M; Dalheim, AV; Salom, JB; Qiu, W; Kaja, S; Alcácer Fernández-Coronado, J; Alandes, S; Alcácer, J; Al-Shahrour, F; Borgia, JA; Juan, O; Nishimura, MI; Lahoz, A; Carretero, J; Shimamura, T Endothelin-1-mediated Drug Resistance in EGFR-mutant NSCLC. Cancer research
  • Yunru Chen Qing Li Kangsheng Tu Yuanguo Wang Xianghu Wang Dandan Liu Chen Chen Donglian Liu Rendong Yang Wei Qiu Ningling Kang Focal Adhesion Kinase Promotes Hepatic Stellate Cell Activation by Regulating Plasma Membrane Localization of TGFß Receptor 2 HEPATOLOGY COMMUNICATION ; 268-283
  • Shang, N; Wang, H; Bank, T; Perera, A; Joyce, C; Kuffel, G; Zilliox, MJ; Cotler, SJ; Ding, X; Dhanarajan, A; Breslin, P; Qiu, W Focal Adhesion Kinase and ß-Catenin Cooperate to Induce Hepatocellular Carcinoma. Hepatology (Baltimore, Md.) ; 70 5
  • Qiu, W REPLY. Hepatology (Baltimore, Md.) ; 70 4
  • Chen, Y; Li, Q; Tu, K; Wang, Y; Wang, X; Liu, D; Chen, C; Liu, D; Yang, R; Qiu, W; Kang, N Focal Adhesion Kinase Promotes Hepatic Stellate Cell Activation by Regulating Plasma Membrane Localization of TGFß Receptor 2. Hepatology communications ; 4 2
  • 1. Shang N, Wang H, Bank T, Perera A, Joyce C, Kuffel G, Michael Z, Cotler S, Ding XZ, Dhanarajan A, Breslin P, Qiu W Focal adhesion kinase and ß-catenin cooperate to induce hepatocellular carcinoma HEPATOLOGY
  • Qiu W Reply to "FAK/CAT network may act as a regulator of HCC epigenetics" Hepatology (Baltimore, Md.)
  • Wang F, Bank T, Malnassy G, Arteaga M, Shang N, Dalheim A, Ding X, Cotler SJ, Denning MF, Nishimura MI, Breslin P, Qiu W Inhibition of insulin-like growth factor 1 receptor enhances the efficacy of sorafenib in inhibiting hepatocellular carcinoma cell growth and survival. Hepatology communications ; 2 6 732-746
  • Shang, N; Bank, T; Ding, X; Breslin, P; Li, J; Shi, B; Qiu, W Caspase-3 suppresses diethylnitrosamine-induced hepatocyte death, compensatory proliferation and hepatocarcinogenesis through inhibiting p38 activation. Cell death & disease ; 9 5
  • Chitsike L, Ding, XZ, Breslin P, Qiu W ABL1 is overexpressed and activated in hepatocellular carcinoma JOURNAL OF CANCER AND TUMOR INTERNATIONAL ; 6 3 1-8
  • Shang, N., Arteaga, M., Zaidi, A., Cotler, S.J., Breslin, P., Ding, X.Z., Kuo, P., Nishimura, M., Zhang, J., Qiu, W. FAK kinase activity is required for the progression of c-Met/ß-catenin-driven HCC GENE EXPRESSION: THE JOURNAL OF BASIC LIVER RESEARCH. ; 17 1 79-88
  • Arteaga, M., Shang, N., Ding, X.Z., Yong, S., Cotler, S.J., Denning, M.F., Shimamura, T., Breslin, P., Bernhard, L., Qiu, W. Inhibition of SIRT2 suppresses hepatic fibrosis. AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY ; 310 11 G1155-68
  • Shang, N., Arteaga, M., Chitsike, L., Wang, F., Viswakarma, N., Breslin, P., Qiu, W. FAK deletion accelerates liver regeneration after two-thirds partial hepatectomy Scientific reports ; 6 34316
  • Shang, N., Arteaga, M., Zaidi, A., Stauffer, J., Cotler, S.J., Zeleznik-Le, N., Zhang, J., Qiu, W FAK is required for c-Met/ß-catenin-driven hepatocarcinogenesis HEPATOLOGY ; 61 1 214-26